Treatment options are often determined by the stage of mesothelioma a patient is in. There are three staging systems currently in use for pleural mesothelioma and each one measures somewhat different variables; peritoneal mesothelioma is not staged.
Staging is the term used to describe the extent of a patient's cancer, based on the primary tumor and its spread in the body. It can help the medical team plan treatment, estimate prognosis and identify clinical trials for which the patient may be eligible.
Staging is based on a knowledge of how the cancer develops, from the primary tumor, to the invasion of nearby organs and tissues, to distant spread or metastasis. Staging systems have evolved over time, and they continue to change as scientists learn more about cancer. Some staging systems cover many different types of cancer, while others focus on more specific cancers. The TNM (primary tumor, regional lymph nodes, distant metastasis) is the most common staging system for mesothelioma.
Some elements common to most staging systems are:
* Location of the primary tumor.
* Size and number of the tumors.
* Lymph node involvement.
* Cell type and tumor grade.
* Metastasis.
Many cancer registries, such as the National Cancer Institute's Surveillance, Epidemiology, and End Results Program (SEER) use summary staging, a system used for all types of cancer. Summary staging groups cancer into five main categories:
* In situ - cancer that is present only in the layer of cells in which it began.
* Localized - cancer that is limited to the organ in which it began with no evidence of spread.
* Regional - cancer that has spread from the primary site to nearby lymph nodes or organs.
* Distant - cancer that has spread from the primary site to distant lymph nodes or organs.
* Unknown - cases where not enough information exists to indicate stage.
Several types of testing may be used to help doctors determine stage, and to formulate a treatment plan.
* Physical examinations. The doctor examines the body by looking, feeling and listening to anything out of the ordinary.
* Imaging techniques. Procedures such as x-rays, CT scans, MRIs and PET scans may show the location, size of the tumor and whether the cancer has spread.
* Laboratory tests. Studies of blood, urine, fluid and tissue can provide information about the cancer. Tumor markers, sometime elevated when cancer is present, may provide information.
* Pathology reports. Results of the examination of tissue samples can include information about the size of the tumor(s), extension into adjacent structures, type of cells and grade of the tumor. Results of the examination of cells in fluid, such as that from a mesothelioma-related pleural effusion, may also provide information.
* Surgical reports. Observations about the size and appearance of the tumor(s), lymph nodes and nearby organs.
Staging information should be provided to the patient by his doctor so that potential treatment plans can be discussed. Stage of the mesothelioma, as well as consideration of other factors such as age, health status and the patient's wishes may dictate different treatment options.
The oldest staging system and the one most often used is the Butchart System which is based mainly on the extent of primary tumor mass and divides mesotheliomas into four stages. The more recent TNM system considers variables of tumor in mass and spread, lymph node involvement, and metastasis. The Brigham System is the latest system and stages mesothelioma according to resectability (the ability to surgically remove) and lymph node involvement.
Butchart System – extent of primary tumor mass
* Stage I: Mesothelioma is present in the right or left pleura and may also involve the diaphragm on the same side.
* Stage II: Mesothelioma invades the chest wall or involves the esophagus, heart, or pleura on both sides. Lymph nodes in the chest may also be involved.
* Stage III: Mesothelioma has penetrated through the diaphragm into the lining of the abdominal cavity or peritoneum. Lymph nodes beyond those in the chest may also be involved.
* Stage IV: There is evidence of metastasis or spread through the bloodstream to other organs.
TNM System -- variables of T (tumor), N (lymph nodes), M (metastasis)
* Stage I: Mesothelioma involves right or left pleura and may also have spread to the lung, pericardium, or diaphragm on the same side. Lymph nodes are not involved.
* Stage II: Mesothelioma has spread from the pleura on one side to nearby lymph nodes next to the lung on the same side. It may also have spread into the lung, pericardium, or diaphragm on the same side.
* Stage III: Mesothelioma is now in the chest wall, muscle, ribs, heart, esophagus, or other organs in the chest on the same side with or without spread to lymph nodes on the same side as the primary tumor.
* Stage IV: Mesothelioma has spread into the lymph nodes in the chest on the side opposite the primary tumor, or extends to the pleura or lung on the opposite side, or directly extends into organs in the abdominal cavity or neck. Any distant metastases is included in this stage.
Brigham System: (variables of tumor resectability and nodal status)
* Stage I: Resectable mesothelioma and no lymph node involvement
* Stage II: Resectable mesothelioma but with lymph node involvement
* Stage III: Unresectable mesothelioma extending into chest wall, heart, or through diaphragm, peritoneum; with or without extrathoracic lymph node involvement
* Stage IV: Distant metastatic disease.
Sunday, June 7, 2009
New techniques for diagnosis.
• Magnetic Resonance Imaging (MRI)
MRI scans are most often used to determine the extent of tumor prior to aggressive treatment. Because they provide images in multiple planes, they are better able to identify tumors as opposed to normal structures. They are also more accurate than CT scans in assessing enlargement of the mediastinal lymph nodes (those lymph nodes which lie between the two lungs), as well as a clear diaphragmatic surface, both of which play an important role in surgical candidacy.
• Positron Emission Tomography (PET)
PET imaging is now becoming an important part of the diagnosis and evaluation of mesothelioma. While PET scans are more expensive than other types of imaging, and are not always covered under insurance, they are now considered to be the most diagnostic of tumor sites, as well as the most superior in determining the staging of mesothelioma. Further explanation of PET scans.
• CT/PET
For patients who may be candidates for aggressive multimodality treatment (surgery, chemotherapy and radiation), accurate clinical staging is extremely important. Integrated CT/PET imaging provides a relatively new tool in this respect, and has become the imaging technique of choice for determining surgical eligibility. By combining the benefits of CT and PET (anatomic and metabolic information) into a single scan, this technology can more accurately determine the stage of the cancer, and can help identify the best treatment option for the patient. Read about a study of CT-PET imaging in preoperative evaluation of patients with malignant pleural mesothelioma.
A needle biopsy of the mass, or the removal and examination of the fluid surrounding the lung, may be used for diagnosis, however, because these samples are sometimes inadequate as far as determining cell type (epithelial, sarcomatous, or mixed) or because of the unreliability of fluid diagnosis, open pleural biopsy may be recommended. In a pleural biopsy procedure, a surgeon will make a small incision through the chest wall and insert a thin, lighted tube called a thoracoscope into the chest between two ribs. He will then remove a sample of tissue to be reviewed under a microscope by a pathologist. In a peritoneal biopsy, the doctor makes a small incision in the abdomen and inserts a peritoneoscope into the abdominal cavity.
Once mesothelioma is suspected through imaging tests, it is confirmed by pathological examination. Tissue is removed, put under the microscope, and a pathologist makes a definitive diagnosis, and issues a pathology report. This is the end of a process that usually begins with symptoms that send most people to the doctor: a fluid build-up or pleural effusions, shortness of breath, pain in the chest, or pain or swelling in the abdomen. The doctor may order an x-ray or CT scan of the chest or abdomen. If further examination is warranted, the following tests may be done:
In many cases, this video-assisted technique is able to replace thoracotomy, which requires a much larger incision to gain access to the chest cavity, and because it is minimally invasive, the patient most often has less post-operative pain and a potentially shorter recovery period.
MRI scans are most often used to determine the extent of tumor prior to aggressive treatment. Because they provide images in multiple planes, they are better able to identify tumors as opposed to normal structures. They are also more accurate than CT scans in assessing enlargement of the mediastinal lymph nodes (those lymph nodes which lie between the two lungs), as well as a clear diaphragmatic surface, both of which play an important role in surgical candidacy.
• Positron Emission Tomography (PET)
PET imaging is now becoming an important part of the diagnosis and evaluation of mesothelioma. While PET scans are more expensive than other types of imaging, and are not always covered under insurance, they are now considered to be the most diagnostic of tumor sites, as well as the most superior in determining the staging of mesothelioma. Further explanation of PET scans.
• CT/PET
For patients who may be candidates for aggressive multimodality treatment (surgery, chemotherapy and radiation), accurate clinical staging is extremely important. Integrated CT/PET imaging provides a relatively new tool in this respect, and has become the imaging technique of choice for determining surgical eligibility. By combining the benefits of CT and PET (anatomic and metabolic information) into a single scan, this technology can more accurately determine the stage of the cancer, and can help identify the best treatment option for the patient. Read about a study of CT-PET imaging in preoperative evaluation of patients with malignant pleural mesothelioma.
A needle biopsy of the mass, or the removal and examination of the fluid surrounding the lung, may be used for diagnosis, however, because these samples are sometimes inadequate as far as determining cell type (epithelial, sarcomatous, or mixed) or because of the unreliability of fluid diagnosis, open pleural biopsy may be recommended. In a pleural biopsy procedure, a surgeon will make a small incision through the chest wall and insert a thin, lighted tube called a thoracoscope into the chest between two ribs. He will then remove a sample of tissue to be reviewed under a microscope by a pathologist. In a peritoneal biopsy, the doctor makes a small incision in the abdomen and inserts a peritoneoscope into the abdominal cavity.
Once mesothelioma is suspected through imaging tests, it is confirmed by pathological examination. Tissue is removed, put under the microscope, and a pathologist makes a definitive diagnosis, and issues a pathology report. This is the end of a process that usually begins with symptoms that send most people to the doctor: a fluid build-up or pleural effusions, shortness of breath, pain in the chest, or pain or swelling in the abdomen. The doctor may order an x-ray or CT scan of the chest or abdomen. If further examination is warranted, the following tests may be done:
- Video-Assisted Thoracoscopic Surgery (VATS)
In many cases, this video-assisted technique is able to replace thoracotomy, which requires a much larger incision to gain access to the chest cavity, and because it is minimally invasive, the patient most often has less post-operative pain and a potentially shorter recovery period.
Diagnosis of Mesothelioma
Mesothelioma is diagnosed by pathological examination from a biopsy. Tissue is removed, placed under the microscope, and a pathologist makes a definitive diagnosis and issues a pathology report. This is the end of a process that usually begins with symptoms that send most people to the doctor: a fluid buildup around the lungs (pleural effusions), shortness of breath, pain in the chest, or pain or swelling in the abdomen. The doctor may order an X-ray or CT scan of the chest or abdomen. If further examination is warranted, the following tests may be done:
For pleural mesothelioma, the doctor may look inside the chest cavity with a special instrument called a thoracoscope. A cut will be made through the chest wall and the thoracoscope will be put into the chest between two ribs. This test is usually done in a hospital using a local anesthetic or painkiller.
If fluid has collected in your chest, your doctor may drain the fluid out of your body by putting a needle into your chest and using gentle suction to remove the fluid. This is called thoracentesis.
For peritoneal mesothelioma, the doctor may also look inside the abdomen with a special tool called a peritoneoscope. The peritoneoscope is put into an opening made in the abdomen. This test is usually done in the hospital under a local anesthetic.
If fluid has collected in your abdomen, your doctor may drain the fluid out of your body by putting a needle into your abdomen and using gentle suction to remove the fluid. This process is called paracentesis.
If abnormal tissue is found, the doctor will need to cut out a small piece and have it looked at under a microscope. This is usually done during the thoracoscopy or peritoneoscopy, but can be done during surgery.
Unfortunately, in some cases, tumor cells can grow along the tract where the biopsy is taken. This can be minimized with the use of radiation to the area.
source:
www.medicinenet.com
- Thoracoscopy
For pleural mesothelioma, the doctor may look inside the chest cavity with a special instrument called a thoracoscope. A cut will be made through the chest wall and the thoracoscope will be put into the chest between two ribs. This test is usually done in a hospital using a local anesthetic or painkiller.
If fluid has collected in your chest, your doctor may drain the fluid out of your body by putting a needle into your chest and using gentle suction to remove the fluid. This is called thoracentesis.
- Peritoneoscopy
For peritoneal mesothelioma, the doctor may also look inside the abdomen with a special tool called a peritoneoscope. The peritoneoscope is put into an opening made in the abdomen. This test is usually done in the hospital under a local anesthetic.
If fluid has collected in your abdomen, your doctor may drain the fluid out of your body by putting a needle into your abdomen and using gentle suction to remove the fluid. This process is called paracentesis.
- Biopsy
If abnormal tissue is found, the doctor will need to cut out a small piece and have it looked at under a microscope. This is usually done during the thoracoscopy or peritoneoscopy, but can be done during surgery.
Unfortunately, in some cases, tumor cells can grow along the tract where the biopsy is taken. This can be minimized with the use of radiation to the area.
source:
www.medicinenet.com
Symptoms of Mesothelioma
- Exercise symptoms: Symptoms related to or triggered by exercise.
- chest pain
- Persistent cough: Cough that remains or becomes chronic.
- Bronchitis: Inflammation of the bronchi as a symptom.
- Breathlessness: Breathing difficulty of any kind (or any kind of "shortness of breath") is a potentially life-threatening emergency.
- Pleural effusion, or fluid surrounding the lung .
- Wheezing: Breathing difficulty with specific wheezing sound.
- Fatigue or anemia.
- Hoarseness of voice.
- Hemoptysis: Where a person coughs up blood.
- Weight loss .
- Increased abdominal girth.
- Distention of the abdomen.
- Changes in bowel habits.
- Development of lumps under the skin on the abdomen .
- Ascites: The presence of serous fluid within the abdominal cavity.
Fever.
- Digestive disturbances.
Types of mesothelioma
Pleural mesothelioma:
Pleural mesothelioma is the main type of mesothelioma that is typically similar to lung cancer. However, there are also other types of mesothelioma affecting the heart (pericardial mesothelioma) and abdomen (peritoneal mesothelioma).
Peritoneal mesothelioma:
Peritoneal mesothelioma is a type of mesothelioma affecting the peritoneum (abdominal membrane).
Pericardial Mesothelioma:
Pericardial mesothelioma, or mesothelioma of the pericardium, is a disease that affects the lining of the heart.
Malignant mesothelioma:
Malignant mesothelioma affects the lining or membranes of certain large cavities in the body. These cavities, called the serous cavities, house certain major organs in the body including the heart, lungs, abdomen and others.
Benign mesothelioma:
Benign mesothelioma refers to any type of mesothelioma that is non-cancerous; Unlike most cancerous mesothelioma cases, benign mesothelioma is not usually related to asbestos.
Sarcomatoid Mesothelioma:
Sarcomatoid mesothelioma accounts for only about 10 to 15 percent of the mesothelioma cancer cells and it is the least common form of mesothelioma. It appears as spindle-shaped pattern of cells that overlap one another, and generally arises from support tissues such as bone, cartilage, muscle, and fat.
Biphasic Mesothelioma:
Biphasic mesothelioma is the second most common type of mesothelioma cancer cell Biphasic mesothelioma, or mixed mesothelioma, contains a mixture of epithelioid and sarcomatoid cells.
Epitheloid mesothelioma .
source:
Mesothelioma
by Bruce W S Robinson (Editor), A Philippe Chahinian (Editor)
Pleural mesothelioma is the main type of mesothelioma that is typically similar to lung cancer. However, there are also other types of mesothelioma affecting the heart (pericardial mesothelioma) and abdomen (peritoneal mesothelioma).
Peritoneal mesothelioma:
Peritoneal mesothelioma is a type of mesothelioma affecting the peritoneum (abdominal membrane).
Pericardial Mesothelioma:
Pericardial mesothelioma, or mesothelioma of the pericardium, is a disease that affects the lining of the heart.
Malignant mesothelioma:
Malignant mesothelioma affects the lining or membranes of certain large cavities in the body. These cavities, called the serous cavities, house certain major organs in the body including the heart, lungs, abdomen and others.
Benign mesothelioma:
Benign mesothelioma refers to any type of mesothelioma that is non-cancerous; Unlike most cancerous mesothelioma cases, benign mesothelioma is not usually related to asbestos.
Sarcomatoid Mesothelioma:
Sarcomatoid mesothelioma accounts for only about 10 to 15 percent of the mesothelioma cancer cells and it is the least common form of mesothelioma. It appears as spindle-shaped pattern of cells that overlap one another, and generally arises from support tissues such as bone, cartilage, muscle, and fat.
Biphasic Mesothelioma:
Biphasic mesothelioma is the second most common type of mesothelioma cancer cell Biphasic mesothelioma, or mixed mesothelioma, contains a mixture of epithelioid and sarcomatoid cells.
Epitheloid mesothelioma .
source:
Mesothelioma
by Bruce W S Robinson (Editor), A Philippe Chahinian (Editor)
Mesothelioma Risk Factors
Asbestos Exposure
Asbestos exposure is the primary risk factor for mesothelioma. Asbestos is a group of minerals once used in industrial and construction materials, but is now produced in small quantities. Asbestos was once found in products like:
tile and flooring
insulation
door gaskets
roofing materials
cement
plaster of paris
joint compound
textured paint
It is estimated that about 8 million Americans have been exposed to asbestos. It generally takes 20-50 years for mesothelioma symptoms to present themselves after a person is exposed to asbestos.
Smoking and Asbestos Exposure
The combination of tobacco smoking and exposure to asbestos can greatly increase the risk factor for developing mesothelioma. According to the American Cancer Society, no studies currently link smoking alone to mesothelioma.
Radiation
In the past, certain x-rays used a material called thorium doxide. It was later to have been found to cause mesothelioma. Fortunately, it is no longer in use.
Zeolite
Zeolite is a natural occurring mineral in the Turkish region, Anatoli. Zeolite is found in the soil and is very similar to asbestos.
Asbestos exposure is the primary risk factor for mesothelioma. Asbestos is a group of minerals once used in industrial and construction materials, but is now produced in small quantities. Asbestos was once found in products like:
It is estimated that about 8 million Americans have been exposed to asbestos. It generally takes 20-50 years for mesothelioma symptoms to present themselves after a person is exposed to asbestos.
Smoking and Asbestos Exposure
The combination of tobacco smoking and exposure to asbestos can greatly increase the risk factor for developing mesothelioma. According to the American Cancer Society, no studies currently link smoking alone to mesothelioma.
Radiation
In the past, certain x-rays used a material called thorium doxide. It was later to have been found to cause mesothelioma. Fortunately, it is no longer in use.
Zeolite
Zeolite is a natural occurring mineral in the Turkish region, Anatoli. Zeolite is found in the soil and is very similar to asbestos.
Diseases of the mesothelium
* Mesothelioma: (cancer of the mesothelium) is a disease in which cells of the mesothelium become abnormal and divide without control or order. They can invade and damage nearby tissues and organs. Cancer cells can also metastasize (spread) from their original site to other parts of the body. Most cases of mesothelioma begin in the pleura or peritoneum. More than 90% of mesothelioma cases are linked to asbestos exposure.
* Intra-abdominal adhesions: Normally, the mesothelium secretes plasminogen, which removes fibrin deposits. During surgical procedures, the mesothelium may be damaged. Its fibrinolytic capacity becomes insufficient and fibrin accumulates, causing fibrous adhesions between opposing surfaces. These adhesions cause intestinal obstruction and female infertility if it occurs in the abdomen, and may impair cardiac and lung function in the thorax.
* Ultrafiltration failure: The peritoneal mesothelium is implicated in the long-term development of ultrafiltration failure in peritoneal dialysis patients. The presence of supra-physiological glucose concentrations, acidity, and glucose degradation products in peritoneal dialysis fluids contribute to the fibrosis of the peritoneal mesothelium, either by epithelial-mesenchymal transition or increased proliferation of existing fibroblasts. A fibrosed peritoneum results in the increased passage of solutes across the peritoneum and ultrafiltration failure.
source :
Histology at KUMC
wikipedia.org/wiki/Mesothelium
What is the mesothelium ?
The mesothelium is a membrane that forms the lining of several body cavities: the pleura (thoracal cavity), peritoneum (abdominal cavity including the mesentery) and pericardium (heart sac). Mesothelial tissue also surrounds the male internal reproductive organs (the tunica vaginalis testis) and covers the internal reproductive organs of women (the tunica serosa uteri). Mesothelium that covers the internal organs is called visceral mesothelium, while the layer that covers the body walls is called the parietal mesothelium.
Origin
Mesothelium derives from the embryonic mesoderm cell layer, that lines the coelom (body cavity) in the embryo. It develops into the layer of cells that covers and protects most of the internal organs of the body.
Structure
The mesothelium forms a monolayer of flattened squamous-like epithelial cells resting on a thin basement membrane supported by connective tissue. Cuboidal mesothelial cells may be found at areas of injury, the milky spots of the omentum, and the peritoneal side of the diaphragm overlaying the lymphatic lacunae. The luminal surface is covered with microvilli. The proteins and serosal fluid trapped by the microvilli provide a frictionless surface for internal organs to slide past one another.
Function
The mesothelium is composed of an extensive monolayer of specialized cells (mesothelial cells) that line the body's serous cavities and internal organs. The main purpose of these cells is to produce a lubricating fluid that is released between layers, providing a slippery, non-adhesive and protective surface to facilitate intracoelomic movement.
The mesothelium is also implicated in the transport and movement of fluid and particulate matter across the serosal cavities, leukocyte migration in response to inflammatory mediators, synthesis of pro-inflammatory cytokines, growth factors and extracellular matrix proteins to aid in serosal repair, and the release of factors to promote the disposition and clearance of fibrin (such as plasminogen). It is an antigen presenting cell. Furthermore, the secretion of glycosaminoglycans and lubricants may protect the body against infection and tumor dissemination.
sources
wikipedia.org/wiki/Mesothelium
Mutsaers SE. "Mesothelial cells: Their structure, function, and role in serosal repair."
Subscribe to:
Posts (Atom)